Velan Capital Investment Management’s Edesa Biotech EDSA Stock Holding History

Velan Capital Investment Management’s Portfolio EDSA Stock Details EDSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.73M	Hold	827,500	–	–	4.1%	9
2026 Q1	$4.33M	Buy	827,500 +140,000	+20%	+$420K	2.71%	11
2025 Q4	$976K	Hold	687,500	–	–	0.57%	26
2025 Q3	$1.7M	Hold	687,500	–	–	1.6%	21
2025 Q2	$1.4M	Hold	687,500	–	–	1.38%	20
2025 Q1	$1.68M	Buy	+687,500	New	+$1.48M	1.73%	15
2023 Q4	–	Sell	-183,088	Closed	-$810K	–	24
2023 Q3	$810K	Hold	183,088	–	–	0.65%	23
2023 Q2	$1.04M	Hold	183,088	–	–	0.97%	24
2023 Q1	$1.17M	Buy	183,088 +56,104	+44%	+$586K	1%	19
2022 Q4	$1.92M	Buy	+126,984	New	+$945K	1.7%	15

Other funds holding EDSA

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Velan Capital Investment Management's EDSA Position: Q2 2026 in Review

Velan Capital Investment Management held its Edesa Biotech (EDSA) position steady in Q2 2026 at 827,500 shares worth $6.73M. The position accounts for 4.1% of the portfolio, ranked #9.

Velan Capital Investment Management first reported a position in EDSA in Q4 2022 and has held it in 10 quarters since. 33 funds tracked by Wall St. Rank hold EDSA as of Q2 2026.

Velan Capital Investment Management held 827,500 shares of Edesa Biotech worth $6.73M as of Q2 2026.
Velan Capital Investment Management left its Edesa Biotech share count unchanged in Q2 2026.
Edesa Biotech made up 4.1% of Velan Capital Investment Management's portfolio in Q2 2026, its #9 holding.
Velan Capital Investment Management first reported a position in Edesa Biotech in Q4 2022 and has held it in 10 quarters since.
33 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2026.

Based on Velan Capital Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.